GAS6 and colitis: Paradoxically, experimental evidence has demonstrated that the marked susceptibility to experimentally induced colitis observed in mutant mice lacking Gas6 as well as Axl and Mer correlates with increased incidence of colon cancer, resulting in larger tumors and reduced overall survival [55,56].